Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-11-16FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) from Upsher-Smith Laboratories, LLC. The action modifies/exp…
-
FDA approval · 2007-11-07FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., approving changes to the approved generi…
-
FDA approval · 2007-10-30FDA Approved: DIGOXIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Digoxin under an original ANDA, allowing generic Digoxin from Hikma Pharmaceuticals USA Inc. to be marketed.
-
FDA label_change · 2007-10-18FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Safety and Efficacy Study of RENEWAL 4 AVT [Phase 2, Phase 3]
Phase 2/3 safety and efficacy study of the RENEWAL 4 AVT has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-06-25Clinical Trial Update: Maximum Targeted Ablation of Atrial Flutter [Phase 4]
Phase 4 clinical trial update on maximum targeted ablation for atrial flutter; the current status is unknown.
-
FDA approval · 2007-06-14FDA Approved: DIGOXIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Digoxin from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2007-05-11FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
FDA approval · 2007-04-27FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) from Bausch Health US LLC.
-
FDA approval · 2007-04-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc., granting approval of a supplemental indicatio…
-
FDA approval · 2007-04-12FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., confirming regulatory approval of an upda…
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., updating the approval status for this generic…
-
FDA approval · 2007-04-11FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2007-03-07FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Dr. Reddy's Laboratories Inc., enabling the generic product's …
-
FDA approval · 2007-03-01FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for Sotalol Hydrochloride (Oxford Pharmaceuticals, LLC), updating an existing approved product.
-
FDA approval · 2007-02-07FDA Approved: SOTALOL HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for sotalol hydrochloride (generic) from Aurobindo Pharma Limited, authorizing its marketing as a …
-
FDA approval · 2007-01-19FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2006-12-26FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for sotalol hydrochloride, a generic antiarrhythmic, under the AN…
-
FDA approval · 2006-12-04FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) submitted by Actavis Pharma, Inc., authorizing changes to th…
-
EMA withdrawal · 2006-09-08EMA Application withdrawn: Multaq (dronedarone) — Sanofi-Aventis
EMA withdrew the application for Multaq (dronedarone) for atrial fibrillation/flutter.
-
FDA approval · 2006-05-04FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited, authorizing a generic Propafe…